StockData
BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc (BCRX) stock

BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$7.30−0.20 (-2.67%)

Close on Nov 18, 2026Market cap $1.87BP/E –Yield –

BioCryst Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioCryst Pharmaceuticals's market cap was $1.95B on Nov 11, 2026, against $1.51B a year earlier. Over the last 5 years it ranged from $849.83M to $3.06B, with a median of $1.71B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.95B+18.9%
2025Dec 31, 2025$1.64B+5.4%
2024Dec 31, 2024$1.56B+37.0%
2023Dec 29, 2023$1.14B-46.9%
2022Dec 30, 2022$2.14B-14.1%
2021Dec 31, 2021$2.49B+89.3%
2020Dec 31, 2020$1.32B+245.2%
2019Dec 31, 2019$381.01M-56.9%
2018Dec 31, 2018$884.67M+83.1%
2017Dec 29, 2017$483.09M+3.5%
2016Dec 30, 2016$466.89M-38.3%
2015Dec 31, 2015$756.84M-13.4%
2014Dec 31, 2014$873.83M+94.6%
2013Dec 31, 2013$449.09M+521.6%
2012Dec 31, 2012$72.25M+64621.2%
2011Dec 30, 2011$111.63K–

More BioCryst Pharmaceuticals figures

See a number that looks wrong?